“Assessing Medical Menstrual Regulation in the United States”
This study will assess the acceptability and use of medical menstrual regulation among women in the United States.
Drug - Mifepristone
All participants will receive 200 mg mifepristone, to be taken orally on day 1.
Drug - Misoprostol
All participants will receive 800 mcg misoprostol, to be taken buccally 24 hours after mifepristone (day 2)
Assessing Acceptability and Use of Medical Menstrual Regulation in the United States